On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip

Tomoyuki Kaneko, Fumimasa Nomura, Tomoyo Hamada, Yasuyuki Abe, Hideo Takamori, Tomoko Sakakura, Kiyoshi Takasuna, Atsushi Sanbuissho, Johan Hyllner, Peter Sartipy, Kenji Yasuda

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

To overcome the limitations and misjudgments of conventional prediction of arrhythmic cardiotoxicity, we have developed an on-chip in vitro predictive cardiotoxicity assay using cardiomyocytes derived from human stem cells employing a constructive spatiotemporal two step measurement of fluctuation (short-term variability; STV) of cell's repolarization and cell-to-cell conduction time, representing two origins of lethal arrhythmia. Temporal STV of field potential duration (FPD) showed a potential to predict the risks of lethal arrhythmia originated from repolarization dispersion for false negative compounds, which was not correctly predicted by conventional measurements using animal cells, even for non-QT prolonging clinical positive compounds. Spatial STV of conduction time delay also unveiled the proarrhythmic risk of asynchronous propagation in cell networks, whose risk cannot be correctly predicted by single-cell-based measurements, indicating the importance of the spatiotemporal fluctuation viewpoint of in vitro cell networks for precise prediction of lethal arrhythmia reaching clinical assessment such as thorough QT assay.

Original languageEnglish
Article number4670
JournalScientific Reports
Volume4
DOIs
Publication statusPublished - 2014 Apr 22
Externally publishedYes

Fingerprint

Cardiac Myocytes
Cardiac Arrhythmias
Cardiotoxicity
In Vitro Techniques
Stem Cells

ASJC Scopus subject areas

  • General
  • Medicine(all)

Cite this

On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip. / Kaneko, Tomoyuki; Nomura, Fumimasa; Hamada, Tomoyo; Abe, Yasuyuki; Takamori, Hideo; Sakakura, Tomoko; Takasuna, Kiyoshi; Sanbuissho, Atsushi; Hyllner, Johan; Sartipy, Peter; Yasuda, Kenji.

In: Scientific Reports, Vol. 4, 4670, 22.04.2014.

Research output: Contribution to journalArticle

Kaneko, T, Nomura, F, Hamada, T, Abe, Y, Takamori, H, Sakakura, T, Takasuna, K, Sanbuissho, A, Hyllner, J, Sartipy, P & Yasuda, K 2014, 'On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip', Scientific Reports, vol. 4, 4670. https://doi.org/10.1038/srep04670
Kaneko, Tomoyuki ; Nomura, Fumimasa ; Hamada, Tomoyo ; Abe, Yasuyuki ; Takamori, Hideo ; Sakakura, Tomoko ; Takasuna, Kiyoshi ; Sanbuissho, Atsushi ; Hyllner, Johan ; Sartipy, Peter ; Yasuda, Kenji. / On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip. In: Scientific Reports. 2014 ; Vol. 4.
@article{475081e280864ef6968cebf7d13f4641,
title = "On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip",
abstract = "To overcome the limitations and misjudgments of conventional prediction of arrhythmic cardiotoxicity, we have developed an on-chip in vitro predictive cardiotoxicity assay using cardiomyocytes derived from human stem cells employing a constructive spatiotemporal two step measurement of fluctuation (short-term variability; STV) of cell's repolarization and cell-to-cell conduction time, representing two origins of lethal arrhythmia. Temporal STV of field potential duration (FPD) showed a potential to predict the risks of lethal arrhythmia originated from repolarization dispersion for false negative compounds, which was not correctly predicted by conventional measurements using animal cells, even for non-QT prolonging clinical positive compounds. Spatial STV of conduction time delay also unveiled the proarrhythmic risk of asynchronous propagation in cell networks, whose risk cannot be correctly predicted by single-cell-based measurements, indicating the importance of the spatiotemporal fluctuation viewpoint of in vitro cell networks for precise prediction of lethal arrhythmia reaching clinical assessment such as thorough QT assay.",
author = "Tomoyuki Kaneko and Fumimasa Nomura and Tomoyo Hamada and Yasuyuki Abe and Hideo Takamori and Tomoko Sakakura and Kiyoshi Takasuna and Atsushi Sanbuissho and Johan Hyllner and Peter Sartipy and Kenji Yasuda",
year = "2014",
month = "4",
day = "22",
doi = "10.1038/srep04670",
language = "English",
volume = "4",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip

AU - Kaneko, Tomoyuki

AU - Nomura, Fumimasa

AU - Hamada, Tomoyo

AU - Abe, Yasuyuki

AU - Takamori, Hideo

AU - Sakakura, Tomoko

AU - Takasuna, Kiyoshi

AU - Sanbuissho, Atsushi

AU - Hyllner, Johan

AU - Sartipy, Peter

AU - Yasuda, Kenji

PY - 2014/4/22

Y1 - 2014/4/22

N2 - To overcome the limitations and misjudgments of conventional prediction of arrhythmic cardiotoxicity, we have developed an on-chip in vitro predictive cardiotoxicity assay using cardiomyocytes derived from human stem cells employing a constructive spatiotemporal two step measurement of fluctuation (short-term variability; STV) of cell's repolarization and cell-to-cell conduction time, representing two origins of lethal arrhythmia. Temporal STV of field potential duration (FPD) showed a potential to predict the risks of lethal arrhythmia originated from repolarization dispersion for false negative compounds, which was not correctly predicted by conventional measurements using animal cells, even for non-QT prolonging clinical positive compounds. Spatial STV of conduction time delay also unveiled the proarrhythmic risk of asynchronous propagation in cell networks, whose risk cannot be correctly predicted by single-cell-based measurements, indicating the importance of the spatiotemporal fluctuation viewpoint of in vitro cell networks for precise prediction of lethal arrhythmia reaching clinical assessment such as thorough QT assay.

AB - To overcome the limitations and misjudgments of conventional prediction of arrhythmic cardiotoxicity, we have developed an on-chip in vitro predictive cardiotoxicity assay using cardiomyocytes derived from human stem cells employing a constructive spatiotemporal two step measurement of fluctuation (short-term variability; STV) of cell's repolarization and cell-to-cell conduction time, representing two origins of lethal arrhythmia. Temporal STV of field potential duration (FPD) showed a potential to predict the risks of lethal arrhythmia originated from repolarization dispersion for false negative compounds, which was not correctly predicted by conventional measurements using animal cells, even for non-QT prolonging clinical positive compounds. Spatial STV of conduction time delay also unveiled the proarrhythmic risk of asynchronous propagation in cell networks, whose risk cannot be correctly predicted by single-cell-based measurements, indicating the importance of the spatiotemporal fluctuation viewpoint of in vitro cell networks for precise prediction of lethal arrhythmia reaching clinical assessment such as thorough QT assay.

UR - http://www.scopus.com/inward/record.url?scp=84899101781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899101781&partnerID=8YFLogxK

U2 - 10.1038/srep04670

DO - 10.1038/srep04670

M3 - Article

C2 - 24751527

AN - SCOPUS:84899101781

VL - 4

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 4670

ER -